NASH Market Overview 2019

A followup to our NASH Market Research from 2018.

Research Objectives:

  • Understand the current Nonalcoholic steatohepatitis (NASH) treatment landscape and areas of unmet need

  • Explore what physicians know about the current state of affairs in the NASH market and pipeline and what physicians anticipate for the future of NASH treatment

Method: 10-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, US Hepatologists
Sample Size: n=54
Fielding Period: March 6-7, 2019

One key finding:

  • Physicians treat over 30 NASH patients in a typical month and are generally aware of treatments in development for NASH.
    • They are diagnosing these patients using mostly blood tests and ultrasounds and sometimes use transient elastography, liver biopsy, and CT scan

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Instant Insights – Weight Loss Drugs

Instant Insights – Weight Loss Drugs

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...

read more
Post-ASCO Excitement Report

Post-ASCO Excitement Report

Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...

read more
2023 Q1 – NSCLC Essentials Readout

2023 Q1 – NSCLC Essentials Readout

Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...

read more